Pharmafile Logo

Shire adds Sara Mathew to board of directors

Comes as firm aims to become global biotechnology leader

Shire Sara Mathew

Shire has appointed Sara Mathew to its board of directors as a non-executive director.

Mathew who has previously served as chairman, president and CEO of Dun & Bradstreet will also be a member of the audit, compliance and risk committee of the Shire board.

During her 12-year tenure at Dun & Bradstreet she helped transform the company from being a data provider to an innovative digital enterprise that leverages big data, insights and analytics.

In 2013, Mathew was named the top value creator in the S&P 500 by Chief Executive magazine.

Susan Kilsby, chairman at Shire, said: “Sara is a highly-skilled global leader who has demonstrated success in driving strategy and transformation to deliver value for stakeholders.

“Sara also understands first-hand the power of disruptive technologies to substantially influence business in the future, an emerging dynamic in healthcare.

“I am confident that Sara’s unique combination of skills and experience will further enrich the Shire Board of Directors as we advance towards becoming a global biotechnology leader.”

Article by Nikhil Patel
8th September 2015
From: Sales
Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links